InvestorsHub Logo
Followers 21
Posts 1353
Boards Moderated 0
Alias Born 10/28/2011

Re: jtf3 post# 16639

Sunday, 10/13/2013 12:00:06 AM

Sunday, October 13, 2013 12:00:06 AM

Post# of 427253
Sorry but being an accountant by background hard time to grasp all surely thinks the EPA compound can reduce CV from what I read including the Chiba study. Where is the study of VC with statin. Is it the reduce it study which will be complete in 2 years but now at 50% enrollment. So adcom is reviewing whether to grant extension of label to VC with statin based on incomplete study can it be done
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News